Litcius/Paper detail

Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial

Judy C. Boughey, Hongmei Yu, Kayla Switalla, Ladores Velle, Alex Lopes, Anne M. Wallace, Rachel B. Lancaster, Chantal Reyna, Todd M. Tuttle, Nora Jaskowiak, Julia Tchou, Roshni Rao, Marie Catherine Lee, Arpana Naik, Mehra Golshan, Cletus A. Arciero, Candice A. M. Sauder, Cindy Matsen, Christina Yau, Laura J. Esserman, Rita A. Mukhtar, the I-SPY2 Locoregional Working Group

2025Annals of Surgical Oncology11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineSurgical oncologyBreast cancerNeoadjuvant therapyOncologyChemotherapyDe-escalationInternal medicineClinical trialBreast surgeryAxillaGeneral surgeryCancerBreast Cancer Treatment StudiesBreast Lesions and CarcinomasBreast Implant and Reconstruction
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial | Litcius